Subscribe free

HPB & Spleen ·

Liver Transplantation in Primary Liver Cancer: A Personalized Approach

Liver transplantation (LT) is critical for selected patients with primary liver cancers, with evolving strategies improving eligibility and outcomes through personalized treatment plans.

  • Patient selection now involves a “window of eligibility” that assesses overall survival rather than just technical feasibility.
  • Neoadjuvant therapies, including bridging and downstaging, expand transplant eligibility for patients with advanced tumors.
  • Emerging biomarkers, such as circulating tumor DNA, could enhance candidate selection and early detection of recurrence.

Surgeons should consider these new strategies to refine patient selection and improve post-transplant management, ultimately aiming for better outcomes in liver cancer treatment.

Review by Mazzaferro V, Pinter M (…) Tabrizian P et 2 al. in J Hepatol

Copyright © 2026. Published by Elsevier B.V.

read the whole article in J Hepatol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

All papers in HPB & Spleen →